Abstract
Reduced folate carrier is an essential folate transporter and the A80G polymorphism in reduced folate carrier 1 gene (rs1051266) has been shown to be associated with alterations in folate metabolism and consequently cancer development. We evaluated the association of this polymorphism with head and neck squamous cell carcinoma risk in a case–control study of 322 head and neck carcinoma patients and 531 individuals without cancer in a Brazilian population and association of this polymorphism with clinical histopathological parameters, and gender and lifestyle factors. The PCR-RFLP technique was used to genotype the polymorphism and multiple logistic regression was used for comparation between the groups and for interaction between the polymorphism and risk factors and clinical histopathological parameters. We observed association between the RFC1 A80G polymorphism and the risk of this disease. Male gender, tobacco habit and RFC1 AG or GG genotypes may be predictors of this disease (P < 0.05). The genotype, 80AG or GG was associated with for >50 years, male gender and non alcohol consumption (P ≤ 0.05). The polymorphism did not show any association with the primary site, aggressiveness, lymph node involvement or extension of the tumor. In conclusion tobacco and male gender are associated with etiology of this disease and our data provide evidence that supports an association between the RFC1 A80G polymorphism and head and neck squamous cell carcinoma risk, male gender, alcohol non consumption and age over 50 years. However, further studies of folate and plasma concentrations may contribute to the better understanding of the factors involved in the head and neck squamous cell carcinoma etiology.
Similar content being viewed by others
References
Salzwimmer M (2008) Best supportive care in HNSCC. Wien Med Wochenschr 158:278–282
Chen YJ, Chang JT, Liao CT, Wang HM, Yen TC, Chiu CC, Lu YC, Li HF, Cheng AJ (2008) HNSCC in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci 99:1507–1514
Marcu LG, Yeoh E (2009) A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment. J Cancer Res Clin Oncol 135(10):1303–1314
Zhang Z, Shi Q, Liu Z, Sturgis EM, Spitz MR, Wei Q (2005) Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case–control analysis. Cancer Epidemiol Biomark Prev 14:1188–1193
Suzuki T, Matsuo K, Hasegawa Y, Hiraki A, Wakai K, Hirose K et al (2007) One-carbon metabolism-related gene polymorphisms and risk of HNSCC carcinoma: case–control study. Cancer Sci 09:1439–1446
Poeta ML, Manola J, Goldwasser MA et al (2007) TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med 357(25):2552–2561
Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP et al (2007) Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of HNSCC: pooled analysis in the International HNSCC Epidemiology Consortium. J Natl Cancer Inst 99(10):777–789
Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP et al (2008) Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of HNSCC: pooled analysis in the International HNSCC Epidemiology Consortium. J Natl Cancer Inst 99(10):777–789, 2007. Erratum in: J Natl Cancer Inst 100(3):225
Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371:1695–1709
Kruszyna L, Lianeri M, Rydzanicz M, Gajecka M, Szyfter K, Jagodzinski PP (2009). Polymorphic variants of folate metabolism genes and the risk of laryngeal cancer. Mol Biol Rep (Print) 1573–4978 (Online)
Olivieri ERB, Da Silva SD, Mendonça FF, Urata YN, Vidal DO, Faria MAM, Nishimoto IN, Rainho CA, Kowalski LP, Rogatto SR (2009) CYP 1A2*1C, CYP 2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in HNSCC squamous cell carcinoma patients. Oral Oncol 45:73–79
Xu WH, Shrubsole MJ, Xiang YB, Cai Q, Zhao GM, Ruan ZX, Cheng JR, Zheng W, Xo Shu (2007) Dietary folate intake, MTHFR genetic polymorphisms, and the risk of endometrial cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 16:281–287
Solomon PR, Selvam GS, Shanmugam G (2008) Polymorphism in ADH and MTHFR genes in oral squamous cell carcinoma of Indians. Oral Dis 14:633–639
Smith AD, Kim YI, Refsum H (2008) Is folic acid good for everyone? Am J Clin Nutr 87:517–533
Li D, Diao Y, Li H, Fang X, Li H (2008) Association of the polymorphisms of MTHFR C677T, VDR C352T, and MPO G463A with risk for esophageal squamous cell dysplasia and carcinoma. Arch Med Res 39:594–600
Jin F, Qu LS, Shen XZ (2009) Association between the methylenetetrahydrofolate reductase C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis. Diagn Pathol 4:39
Finkelstein JD, Martin JJ (2000) Homocysteine. Int J Biochem Cell Biol 32:385–389
Eklof V, Van GB, Hultdin J, Johansson I, Hallmans G, Palmqvist R (2007) The reduced folate carrier (RFC1) 80G>A and folate hydrolase 1 (FOLH1) 1561C>T polymorphisms and the risk of colorectal cancer: a nested case-referent study. Scand J Clin Lab Invest 21:1–9
DeVos L, Chanson A, Liu Z, Ciappio ED, Parnell LD, Mason JB, Tucker KL, Crott JW (2008) Associations between single nucleotide polymorphisms in folate uptake and metabolizing genes with blood folate, homocysteine, and DNA uracil concentrations. Am J Clin Nutr 88(4):1149–1158
Matherly LH, Hou Z, Deng Y (2007) Human reduced folate carrier: translation of basic biology to cancer etiology and therapy. Cancer Metastasis Rev 26:111–128
Stanisławska-Sachadyn A, Mitchell LE, Woodside JV, Buckley PT, Kealey C, Young IS, Scott JM, Murray L et al (2009) The reduced folate carrier (SLC19A1) c.80G>A polymorphism is associated with red cell folate concentrations among women. Ann Hum Genet 73:484–491
Wang L, Chen W, Wang J, Tan Y, Zhou Y, Ding W et al (2006) Reduced folate carrier gene G80A polymorphism is associated with an increased risk of gastroesophageal cancers in a Chinese population. Eur J Cancer 42:3206–3211
Di JJ, Wang JT, Ding L, Wang ZM, Gao ES (2009) A case–control study on the association of RFC-1 polymorphism and cervical cancer. Zhong Liu Xing Bing Xue Za Zhi 30(2):189–191
De Jonge R, Tissing WJE, Hooijberg JH, Jansen G, Kaspers GJL, Jan L, Peters GJ, Pieters R (2009) Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. Blood 113(10):2284–2289
Kotsopoulos J, Zhang WW, Zhang S, McCready D, Trudeau M, Zhang P, Sun P, Narod SA (2008). Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer. Breast Cancer Res Treat. Epub ahead of print
Sobin LH, Wittelind CH (2000) Internacional union against cancer: TNM classification of malignant tumours, 6th ed edn. Wiley, New York
Ahrendt SA, Chown JT, Yang SC, Wu L, Zhang MJ, Jen J, Sidransky D (2000) Alcohol consuption and cigarette smoking increase the frequency of p53 mutations in nonsmall cell lung cancer. Cancer Res 60:3155–3159
Kjaerhein K, Gaard M, Andersen A (1998) The role of alcohol, tobacco, and dietary factors in upper aerogastric tract cancer: a prospective study of 10,900 Norwegian men. Cancer Causes Control 9:99–108
Miller SA, Dikes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Födinger M, Dierkes J, Skoupy S, Röhrer C, Hagen W, Puttinger H et al (2003) Effect of glutamate carboxypeptidase II and reduced folate carrier polymorphisms on folate and total homocysteine concentrations in dialysis patients. J Am Soc Nephrol 14:1314–1319
Werbroucka J, De Ruycka K, Duprezb F, Eijkerenb MV, Rietzschelc E, Bekaertd S, Vrala A, De Neveb W, Thierensa H (2008) Single-nucleotide polymorphisms in DNA double-strand break repair genes: Association with head and neck cancer and interaction with tobacco use and alcohol consumption. Mutat Res 656:74–81
Pytynia KB, Grant JR, Etzel CJ et al (2004) Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck. J Clin Oncol 22:3981–3988
Ragin CCR, Modugno F, Gollin SM (2007) The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res 86:104–114
Lung T, Tascau OC, Almasan HA, Muresan O (2007) HNSCC, epidemiology and histological aspects. Part 1. A decade′s result 1993–2002. J Craniomaxillofac Surg 35:120–125
Argiris A, Karamouzis MV, David Raben D, Ferris RL (2008) HNSCC. J Lancet 371:1695–1709
Boyle P, Leon ME, Maisonneuve P, Autier P (2003) Cancer control in women. Gynecol Obstet 83:179–202
Xu J, Turner A, Little J, Bleecker ER, Meyers DA (2002) Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error? Hum Genet 111:573–574
Llorca J, Prieto-Salceda D, Combarros O, Dierssen-Sotos T, Berciano J (2005) Competing risks of death and Hardy-Weinberg equilibrium in case–control studies of gene-disease association. Gac Sanit 19:321–324
Wittke-Thompson JK, Pluzhnikov A, Cox NJ (2005) Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet 76:967–986
Pei L, Zhu H, Zhu J, Ren A, Finnell RH, Li Z (2006) Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial defects and congenital heart defects in China. Ann Epidemiol 5:352–356
Shang Y, Zhao H, Niu B, Li W, Zhou R, Zhang T, Xie J (2008) Correlation of polymorphism of MTHFRs and RFC-1 genes with neural tube defects in China. Birth Defects Res A 82:3–7
Biselli JM, Brumati D, Frigeri VF, Zampieri BL, Goloni-Bertollo EM, Pavarino-Bertelli EC (2008) A80G polymorphism of reduced folate carrier 1 (RFC1) and C776G polymorphism of transcobalamin 2 (TC2) genes in Down’s syndrome etiology. Sao Paulo Med J 126(6):329–332
Goldstein DP, Irish JC (2005) Head and neck squamous cell carcinoma in the young patient. Curr Opin Otolaryngol Head Neck Surg 13:207–211
Wiseman SM, Sweede H, Stoler DL, Anderson GR, Rigual NR, Hicks WL Jr et al (2003) Squamous cell carcinoma of the head and neck in nonsmokers and nondrinkers: an analysis of clinicopathologic characteristics and treatment outcomes. Ann Surg Oncol 10:551–557
Farshadpour F, Hordijk GJ, Koole R, Slootweg PJ (2008) Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium. J Oral Pathol Med 37:549–554
Mitani T, Hoshikawa H, Mori T, Hosokawa T, Tsukamoto I, Yamaguchi F et al (2009) Growth inhibition of head and neck carcinomas by d-allose. Head Neck 31(8):1049–1055
Tachezy R, Klozar J, Rubenstein L, Smith E, Sálaková M, Šmahelová J et al (2009) Demographic and risk factors in patients with head and neck tumors. J Med Virol 81:878–887
Acknowledgments
The authors wish to thank all those participating in this study. The Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) for their support and FAMERP/FUNFARME.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Galbiatti, A.L.S., Ruiz, M.T., Rezende Pinto, D. et al. A80G polymorphism of reduced folate carrier 1 (RFC1) gene and head and neck squamous cell carcinoma etiology in Brazilian population. Mol Biol Rep 38, 1071–1078 (2011). https://doi.org/10.1007/s11033-010-0204-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-010-0204-1